LTFS
ADIL

Ladenburg Thalmann Financial Services’s Adial Pharmaceuticals ADIL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$25K Buy
17
+10
+143% +$10.5K ﹤0.01% 3996
2019
Q3 		$6K Buy
7
+6
+600% +$6.38K ﹤0.01% 4586
2019
Q2 		$1K Sell
1
-1
-50% -$1.49K ﹤0.01% 5064
2019
Q1 		$4K Buy
2
+1
+100% +$2.98K ﹤0.01% 4712
2018
Q4 		$5K Buy
+1
New +$1.6K ﹤0.01% 4567

Other funds holding ADIL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RWML
RAFFA WEALTH MANAGEMENT, LLC Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ADIL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Adial Pharmaceuticals (ADIL) stake by 143% in Q4 2019, buying an estimated $10.5K and bringing the position to 17 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #3996.

Ladenburg Thalmann Financial Services first reported a position in ADIL in Q4 2018 and has held it in 5 quarters since. 9 funds tracked by Wall St. Rank hold ADIL as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 17 shares of Adial Pharmaceuticals worth $25K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 10 Adial Pharmaceuticals shares in Q4 2019, an estimated $10.5K.
  • Adial Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3996 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Adial Pharmaceuticals in Q4 2018 and has held it in 5 quarters since.
  • 9 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.